Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH.
暂无分享,去创建一个
[1] Mark E. Tuckerman,et al. Reversible multiple time scale molecular dynamics , 1992 .
[2] Farah El Mazouni,et al. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria , 2015, Science Translational Medicine.
[3] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.
[4] Stephen R. Johnson,et al. Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.
[5] Lisa Peltason,et al. Molecular Similarity Analysis in Virtual Screening , 2009 .
[6] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[7] G J Williams,et al. The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.
[8] Hsuan-Liang Liu,et al. The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies , 2011, Journal of Biomedical Science.
[9] David M. Shackleford,et al. A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria. , 2016, ACS infectious diseases.
[10] Honglin Li,et al. Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives. , 2013, Journal of medicinal chemistry.
[11] P. Rathod,et al. High-throughput Screening for Potent and Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase* , 2005, Journal of Biological Chemistry.
[12] D. E. Clark. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.
[13] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[14] P. Rathod,et al. The X-ray structure of Plasmodium falciparum dihydroorotate dehydrogenase bound to a potent and selective N-phenylbenzamide inhibitor reveals novel binding-site interactions. , 2015, Acta crystallographica. Section F, Structural biology communications.
[15] H. Simmonds,et al. Pyrimidine pathways in health and disease. , 2005, Trends in molecular medicine.
[16] A. Wadood,et al. In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase. , 2013, Journal of molecular graphics & modelling.
[17] Conrad C. Huang,et al. Tools for integrated sequence-structure analysis with UCSF Chimera , 2006, BMC Bioinformatics.
[18] Werner Kaminsky,et al. Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds* , 2009, The Journal of Biological Chemistry.
[19] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[20] Santosh A. Khedkar,et al. Pharmacophore modeling in drug discovery and development: an overview. , 2007, Medicinal chemistry (Shariqah (United Arab Emirates)).
[21] T. Ritchie,et al. The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.
[22] Brian K. Shoichet,et al. ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..
[23] Daniela Schuster,et al. Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation , 2011, Bioorganic & medicinal chemistry.
[24] P. Tosco,et al. New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold. , 2012, European journal of medicinal chemistry.
[25] M. Karplus,et al. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .
[26] Tom Fawcett,et al. An introduction to ROC analysis , 2006, Pattern Recognit. Lett..
[27] S. Nosé. A unified formulation of the constant temperature molecular dynamics methods , 1984 .
[28] Jeremy N. Burrows,et al. Fluorine Modulates Species Selectivity in the Triazolopyrimidine Class of Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors , 2014, Journal of medicinal chemistry.
[29] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[30] David M. Shackleford,et al. Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. , 2011, Journal of medicinal chemistry.
[31] Elaine S. Oran,et al. A modified shake algorithm for maintaining rigid bonds in molecular dynamics simulations of large molecules , 1989 .
[32] T Lengauer,et al. CASP2 experiences with docking flexible ligands using FLEXX , 1997, Proteins.
[33] David M. Shackleford,et al. Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. , 2011, Journal of medicinal chemistry.
[34] Bradley I. Coleman,et al. Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model* , 2010, The Journal of Biological Chemistry.
[35] D. Wirth,et al. Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase* , 2008, Journal of Biological Chemistry.
[36] Conrad C. Huang,et al. UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..
[37] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[38] Federico D. Sacerdoti,et al. Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters , 2006, ACM/IEEE SC 2006 Conference (SC'06).
[39] Adrià Cereto-Massagué,et al. DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets , 2012, Bioinform..
[40] V. Barton,et al. Novel inhibitors of the Plasmodium falciparum electron transport chain , 2014, Parasitology.
[41] Andreas Bender,et al. A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication , 2005, J. Chem. Inf. Model..
[42] V. Vyas,et al. Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors. , 2013, Journal of molecular graphics & modelling.
[43] Ling Wang,et al. Three-Dimensional Pharmacophore Modeling of Liver-X Receptor Agonists , 2011, J. Chem. Inf. Model..
[44] S. Planey,et al. The influence of lipophilicity in drug discovery and design , 2012, Expert opinion on drug discovery.
[45] P. Leeson,et al. Drug discovery: Chemical beauty contest , 2012, Nature.
[46] P. Rathod,et al. Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity , 2016, Journal of medicinal chemistry.
[47] A. Christoffels,et al. Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs , 2016, Malaria Journal.
[48] V. Vyas,et al. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity , 2016, SAR and QSAR in environmental research.
[49] V. Ram,et al. Oxygenated chalcones and bischalcones as potential antimalarial agents. , 2000, Bioorganic & medicinal chemistry letters.
[50] M. Klein,et al. Constant pressure molecular dynamics algorithms , 1994 .
[51] P. Rathod,et al. Variations in frequencies of drug resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[52] D. Fidock,et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates , 2015, Science.
[53] Darrell E Hurt,et al. Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor. , 2006, Acta crystallographica. Section D, Biological crystallography.
[54] Joanne M. Morrisey,et al. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.
[55] Ramón García-Domenech,et al. New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. , 2003, The Journal of antimicrobial chemotherapy.
[56] Weltgesundheitsorganisation. World malaria report , 2005 .
[57] Osman F. Güner,et al. Pharmacophore perception, development, and use in drug design , 2000 .
[58] P. Rathod,et al. Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum. , 2008, Journal of medicinal chemistry.
[59] W. L. Jorgensen,et al. Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .
[60] H. Berendsen,et al. Molecular dynamics with coupling to an external bath , 1984 .
[61] D. Wirth,et al. In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth , 2014, The Journal of Biological Chemistry.
[62] S. B. Needleman,et al. A general method applicable to the search for similarities in the amino acid sequence of two proteins. , 1970, Journal of molecular biology.
[63] M. Mobashir,et al. Dihydroorotate dehydrogenase: A drug target for the development of antimalarials. , 2017, European journal of medicinal chemistry.
[64] Hans-Joachim Böhm,et al. The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure , 1994, J. Comput. Aided Mol. Des..
[65] Ravinder Singh,et al. Fast-Find: A novel computational approach to analyzing combinatorial motifs , 2006, BMC Bioinformatics.
[66] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .